Washington Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-98
| Closed | -$47.5K | – | 715 |
|
|
2025
Q1 | $47.5K | Sell |
98
-600
| -86% | -$291K | ﹤0.01% | 417 |
|
|
2024
Q4 | $281K | Sell |
698
-103
| -13% | -$41.5K | 0.01% | 243 |
|
|
2024
Q3 | $373K | Hold |
801
| – | – | 0.01% | 226 |
|
|
2024
Q2 | $375K | Buy |
801
+67
| +9% | +$31.4K | 0.01% | 223 |
|
|
2024
Q1 | $307K | Buy |
734
+43
| +6% | +$18K | 0.01% | 241 |
|
|
2023
Q4 | $281K | Buy |
691
+60
| +10% | +$24.4K | 0.01% | 238 |
|
|
2023
Q3 | $219K | Hold |
631
| – | – | 0.01% | 237 |
|
|
2023
Q2 | $222K | Buy |
631
+9
| +1% | +$3.17K | 0.01% | 246 |
|
|
2023
Q1 | $196K | Hold |
622
| – | – | 0.01% | 253 |
|
|
2022
Q4 | $180K | Hold |
622
| – | – | 0.01% | 260 |
|
|
2022
Q3 | $180K | Buy |
622
+300
| +93% | +$86.8K | 0.01% | 248 |
|
|
2022
Q2 | $91K | Hold |
322
| – | – | ﹤0.01% | 321 |
|
|
2022
Q1 | $84K | Buy |
322
+303
| +1,595% | +$79K | ﹤0.01% | 356 |
|
|
2021
Q4 | $4K | Sell |
19
-5
| -21% | -$1.05K | ﹤0.01% | 774 |
|
|
2021
Q3 | $4K | Buy |
24
+5
| +26% | +$833 | ﹤0.01% | 891 |
|
|
2021
Q2 | $4K | Sell |
19
-4
| -17% | -$842 | ﹤0.01% | 892 |
|
|
2021
Q1 | $5K | Buy |
23
+2
| +10% | +$435 | ﹤0.01% | 829 |
|
|
2020
Q4 | $5K | Hold |
21
| – | – | ﹤0.01% | 808 |
|
|
2020
Q3 | $6K | Buy |
21
+5
| +31% | +$1.43K | ﹤0.01% | 783 |
|
|
2020
Q2 | $5K | Hold |
16
| – | – | ﹤0.01% | 715 |
|
|
2020
Q1 | $4K | Buy |
+16
| New | +$4K | ﹤0.01% | 787 |
|
|
2018
Q3 | – | Sell |
-13
| Closed | -$2K | – | 799 |
|
|
2018
Q2 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 830 |
|